Metabolic Dysfunction-Associated Steatotic Liver Disease and Extrahepatic Cancers
British Journal of Hospital Medicine · 15.10.2026 · 87 (10)
DOI: 10.31083/bjhm50779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 15.10.2026. Verfasst von Shiyu Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Fatty Liver, Neoplasms. Die Arbeit nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Key Research and Development Program, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, and its high prevalence underscores the central role of metabolic dysregulation in its pathogenesis. Recent epidemiological studies have shown that MASLD is associated not only with hepatocellular carcinoma but also with an increased risk of several extrahepatic malignancies, including esophageal, gastric, colorectal, pancreatic, thyroid, breast, endometrial, renal, and prostate cancers. This review summarizes the emerging epidemiological links between MASLD and these extrahepatic cancers and discusses the biological mechanisms that may underlie these associations. We aim to describe both shared and organ-specific pathogenic pathways, highlight the importance of viewing MASLD as a systemic metabolic disorder in cancer prevention and clinical management, and outline future research directions from both conceptual and clinical perspectives. Future efforts should focus on biomarker development, multidisciplinary collaboration, and interventions targeting metabolic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
- Department of Oncology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, China.
- Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China.
- School of Medicine, Shihezi University, 832000 Shihezi, Xinjiang, China.
- Department of Oncology, The First Affiliated Hospital of Jinan University, 510630 Guangzhou, Guangdong, China.
- Department of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China.
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Key Research and Development Program
- Natural Science Foundation of Shandong Province
Zitieren
APA
Peng, S., Ke, Z., Ding, H., Wang, X., Cao, H., Song, Y., Nie, Y., Zhao, Y., Qi, J., & Zhu, Q. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease and Extrahepatic Cancers. British Journal of Hospital Medicine, 87(10). https://doi.org/10.31083/bjhm50779
Vancouver
Peng S, Ke Z, Ding H, Wang X, Cao H, Song Y, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and Extrahepatic Cancers. British Journal of Hospital Medicine. 2026;87(10). doi:10.31083/bjhm50779
BibTeX
@article{Peng2026,
author = {Peng, Shiyu and Ke, Zhui and Ding, Han and Wang, Xinyu and Cao, Huiling and Song, Yuzhu and Nie, Yingying and Zhao, Yang and Qi, Jianni and Zhu, Qiang},
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and Extrahepatic Cancers},
journal = {British Journal of Hospital Medicine},
year = {2026},
volume = {87},
number = {10},
doi = {10.31083/bjhm50779}
}
EUVIMED